Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Jana Buzkova; Joni Nikkanen; Sofia Ahola; Anna H. Hakonen; Ksenia Sevastianova; Topi Hovinen; Hannele Yki-Järvinen; Kirsi H. Pietiläinen; Tuula Lönnqvist; Vidya Velagapudi; Christopher J. Carroll; Anu Suomalainen

doi:10.15252/emmm.201809091

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Jana Buzkova, Joni Nikkanen, Sofia Ahola, Anna H. Hakonen, Ksenia Sevastianova, Topi Hovinen, Hannele Yki-Järvinen, Kirsi H. Pietiläinen, Tuula Lönnqvist, Vidya Velagapudi, Christopher J. Carroll, Anu Suomalainen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	9091
Journal	EMBO molecular medicine
Volume	10
Issue number	12
Number of pages	15
ISSN	1757-4676
DOIs	https://doi.org/10.15252/emmm.201809091
Publication status	Published - Dec 2018
MoE publication type	A1 Journal article-refereed

Fields of Science

biomarker
inclusion body myositis
metabolomics
mitochondrial diseases
ONSET SPINOCEREBELLAR ATAXIA
RECESSIVE ATAXIA
DNA DELETIONS
MELAS
MUTATION
MYOPATHY
HYPERLACTATEMIA
METABOANALYST
PREVALENCE
DEFICIENCY
3111 Biomedicine

Access to Document

10.15252/emmm.201809091

e9091.fullFinal published version, 2.62 MBLicence: CC BY

FIMM Metabolomics (LS-RIA/ Metabo-HiLIFE)
Nieminen, A. I. (Manager)
Institute for Molecular Medicine Finland
Facility/equipment: Core Facility

Cite this

Buzkova, J., Nikkanen, J., Ahola, S., Hakonen, A. H., Sevastianova, K., Hovinen, T., Yki-Järvinen, H., Pietiläinen, K. H., Lönnqvist, T., Velagapudi, V., Carroll, C. J., & Suomalainen, A. (2018). Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers. EMBO molecular medicine, 10(12), Article 9091. https://doi.org/10.15252/emmm.201809091

@article{9f8e64e42ab242639c1c06c59142ee3d,

title = "Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers",

keywords = "biomarker, inclusion body myositis, metabolomics, mitochondrial diseases, ONSET SPINOCEREBELLAR ATAXIA, RECESSIVE ATAXIA, DNA DELETIONS, MELAS, MUTATION, MYOPATHY, HYPERLACTATEMIA, METABOANALYST, PREVALENCE, DEFICIENCY, 3111 Biomedicine",

author = "Jana Buzkova and Joni Nikkanen and Sofia Ahola and Hakonen, {Anna H.} and Ksenia Sevastianova and Topi Hovinen and Hannele Yki-J{\"a}rvinen and Pietil{\"a}inen, {Kirsi H.} and Tuula L{\"o}nnqvist and Vidya Velagapudi and Carroll, {Christopher J.} and Anu Suomalainen",

year = "2018",

month = dec,

doi = "10.15252/emmm.201809091",

language = "English",

volume = "10",

journal = "EMBO molecular medicine",

issn = "1757-4676",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "12",

}

Buzkova, J, Nikkanen, J, Ahola, S, Hakonen, AH, Sevastianova, K, Hovinen, T , Yki-Järvinen, H , Pietiläinen, KH, Lönnqvist, T, Velagapudi, V, Carroll, CJ & Suomalainen, A 2018, 'Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers', EMBO molecular medicine, vol. 10, no. 12, 9091. https://doi.org/10.15252/emmm.201809091

TY - JOUR

T1 - Metabolomes of mitochondrial diseases and inclusion body myositis patients

T2 - treatment targets and biomarkers

AU - Buzkova, Jana

AU - Nikkanen, Joni

AU - Ahola, Sofia

AU - Hakonen, Anna H.

AU - Sevastianova, Ksenia

AU - Hovinen, Topi

AU - Yki-Järvinen, Hannele

AU - Pietiläinen, Kirsi H.

AU - Lönnqvist, Tuula

AU - Velagapudi, Vidya

AU - Carroll, Christopher J.

AU - Suomalainen, Anu

PY - 2018/12

Y1 - 2018/12

KW - biomarker

KW - inclusion body myositis

KW - metabolomics

KW - mitochondrial diseases

KW - ONSET SPINOCEREBELLAR ATAXIA

KW - RECESSIVE ATAXIA

KW - DNA DELETIONS

KW - MELAS

KW - MUTATION

KW - MYOPATHY

KW - HYPERLACTATEMIA

KW - METABOANALYST

KW - PREVALENCE

KW - DEFICIENCY

KW - 3111 Biomedicine

U2 - 10.15252/emmm.201809091

DO - 10.15252/emmm.201809091

M3 - Article

SN - 1757-4676

VL - 10

JO - EMBO molecular medicine

JF - EMBO molecular medicine

IS - 12

M1 - 9091

ER -

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Fields of Science

Access to Document

Equipment

FIMM Metabolomics (LS-RIA/ Metabo-HiLIFE)

Cite this